CoChat

Pentoxifylline for endometriosis

Lu, DongHao, Song, Huan, Li, Yalun, Clarke, Jane, Shi, Gang · 2012 · Cochrane Database of Systematic Reviews
Cited by 38

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Endometriosis is a chronic, recurring condition that occurs during the reproductive years. It is characterized by endometrial tissue developing outside the uterine cavity. This endometrial tissue development is dependent on oestrogen produced primarily by the ovaries and, therefore, traditional management has focused on ovarian suppression. In this review we considered the role of modulation of the immune system as an alternative approach. This is an update of a Cochrane Review previously published in 2009 (Lu 2009). OBJECTIVES: To assess the effects of pentoxifylline, which has anti-inflammatory effects, in subfertile, premenopausal women for the management of endometriosis. SEARCH METHODS: For the first publication of this review we searched the following databases (from inception to December 2008) for trials: Cochrane Menstrual Disorders and Subfertility Group Specialised Register, Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library), MEDLINE, EMBASE, CINAHL, and PsycINFO. In addition, all reference lists of included trials were searched and experts in the field were contacted in an attempt to locate trials. This search was rerun to 23 November 2011, for this update. SELECTION CRITERIA: Randomised controlled trials (RCTs) comparing pentoxifylline with placebo or no treatment, medical treatment, or surgery in subfertile, premenopausal women were included. DATA COLLECTION AND ANALYSIS: Two review authors independently selected trials for inclusion, assessed trial risk of bias, and extracted data using data extraction forms. We contacted study authors for additional information and data. The domains assessed for risk of bias were sequence generation, allocation concealment, blinding, incomplete outcome data, and selective outcome reporting. Peto odds ratios (OR) were used for reporting dichotomous data with 95% confidence intervals (CI), whilst mean differences (MD) were expressed for continuous data. Statistical heterogeneity was assessed using the I(2) statistic. MAIN RESULTS: Four trials involving 334 participants were included. One RCT [n=34] showed pentoxifylline had no significant effect on reduction in pain (MD -1.60, 95% CI -3.32 to 0.12). There was no evidence of an increase in clinical pregnancy events in the pentoxifylline group compared with placebo (three RCTs [n=67] OR 1.54, 95% CI 0.89 to 266). One RCT studied recurrence of endometriosis [n=88] (OR 0.88,95% CI 0.27 to 2.84). No trials reported the effects of pentoxifylline on the odds of live birth rate per woman, improvement of endometriosis-related symptoms, or adverse events. AUTHORS' CONCLUSIONS: This review has been updated in 2011. The results of the original review published in 2009 remain unchanged. There is still not enough evidence to support the use of pentoxifylline in the management of premenopausal women with endometriosis in terms of subfertility and relief of pain outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd007677.pub3

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 14 references

Research works printed but not linked: 36

  1. Alborzi, 2007, Pentoxifylline therapy after laparoscopic surgery for different stages of endometriosis: a prospective, double-blind, randomized, placebo-controlled study, Journal of Minimally Invasive Gynecology, 14(1), 54, 10.1016/j.jmig.2006.06.024 · DOI
  2. Balasch, 1997, Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial, Human Reproduction, 12(9), 2046, 10.1093/humrep/12.9.2046 · DOI · Paper page
  3. Creus, 2008, Combined laparoscopic surgery and pentoxifylline therapy for treatment of endometriosis-associated infertility: A preliminary trial, Human Reproduction, 23(8), 1910, 10.1093/humrep/den167 · DOI · Paper page
  4. Kamencic, 2008, Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial, Journal of Minimally Invasive Gynecology, 15(1), 62, 10.1016/j.jmig.2007.07.018 · DOI
  5. Thiel, 2006, Pentoxifylline (Trental) after conservative surgery for endometriosis: a randomized control trial, Journal of Minimally Invasive Gynecology, 13 Suppl 5, 10
  6. Dravucz, 2001, Endometriosis and infertility: new concepts for treatment by suppression of cytokines, Human Reproduction, 16 Suppl 1, 173
  7. Abu, 2000, Leukotrienes in gynaecology: the hypothetical value of anti-leukotriene therapy in dysmenorrhoea and endometriosis, Human Reproduction Update, 6, 200, 10.1093/humupd/6.2.200 · DOI
  8. Berkkanoglu, 2003, Immunology and endometriosis, American Journal of Reproductive Immunology, 50(1), 48, 10.1034/j.1600-0897.2003.00042.x · DOI · Paper page
  9. Braun, 1998, Endometriosis: abnormal endometrium and dysfunctional immune response, Current Opinion in Obstetrics & Gynecology, 10, 365, 10.1097/00001703-199810000-00003 · DOI · Paper page
  10. Child, 2001, Endometriosis: aetiology, pathogenesis and treatment, Drugs, 61, 1735, 10.2165/00003495-200161120-00005 · DOI
  11. D'Antonio, 2000, Ability of recombinant human TNF binding protein-1 (r-hTBP-1) to inhibit the development of experimentally induced endometriosis in rats, Journal of Reproductive Immunology, 48, 81, 10.1016/S0165-0378(00)00073-5 · DOI
  12. Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315(7109), 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
  13. Farmer, 2003, Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001297 · DOI · Paper page
  14. Farquhar, 2007, Endometriosis, BMJ, 334, 249, 10.1136/bmj.39073.736829.BE · DOI · Paper page
  15. Frampton, 1995, Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders, Drugs & Aging, 7(6), 480, 10.2165/00002512-199507060-00007 · doi:10.2165/00002512-199507060-00007
  16. Furness, 2004, Pre and post operative medical therapy for endometriosis surgery, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003678.pub2 · DOI · Paper page
  17. The Gestrinone Italian Study Group (GISG), 1996, Gestrinone versus a gonadotrophin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double blind study, Fertlity and Sterility, 66, 911, 10.1016/S0015-0282(16)58682-8 · DOI
  18. Halme, 1984, Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis, American Journal of Obstetrics and Gynecology, 148, 85, 10.1016/S0002-9378(84)80037-X · DOI · Paper page
  19. Han, 1990, Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/ tumor necrosis factor synthesis at separate points in the signalling pathway, Journal of Experimental Medicine, 172, 391, 10.1084/jem.172.1.391 · DOI · Paper page
  20. Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
  21. Higgins, 2011, Cochrane Handbook for Systematic Reviews of Interventions
  22. Ingelmo, 1997, Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon-alpha-2b in murine model, Fertility and Sterility, 71, 907, 10.1016/S0015-0282(99)00087-4 · DOI
  23. Keenan, 2000, Regression of endometrial explants in a rat model of endometriosis treated with immune modulators loxoribine and levamisole, Fertility and Sterility, 72, 135, 10.1016/S0015-0282(99)00157-0 · DOI · Paper page
  24. Lebovic, 2001, Immunobiology of endometriosis, Fertility and Sterility, 75(1), 1, 10.1016/S0015-0282(00)01630-7 · DOI · Paper page
  25. Mahmood, 1990, Pathophysiology of mild endometriosis:review of literature, Human Reproduction, 5, 765, 10.1093/oxfordjournals.humrep.a137184 · DOI · Paper page
  26. Nothnick, 1994, Immunomodulation of rat endometriotic implant growth and protein production, American Journal of Reproductive Immunology, 31, 151, 10.1111/j.1600-0897.1994.tb00860.x · DOI · Paper page
  27. Parazzini, 2000, Estroprogestin vs. gonadotrophin agonists plus estroprogest in the treatment of endometriosis-related pelvic pain: a randomized trial, European Journal of Obstetrics, Gynecololgy, and Reproductive Biology, 88, 4
  28. Gilman, 1991, Goodman and Gilman's The Pharmacological Basis of Therapeutics, 408
  29. Steinleitner, 1991, Immunomodulation with pentoxifylline abrogates macrophage-mediated infertility in an in vivo model:a paradigm for a novel approach to the treatment of endometriosis associated subfertility, Fertility and Sterility, 55, 26, 10.1016/S0015-0282(16)54052-7 · DOI
  30. Sullivan, 1988, Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline, Infection and Immunity, 56, 1722, 10.1128/IAI.56.7.1722-1729.1988 · DOI · Paper page
  31. Viganò, 2003, Use of estrogen antagonists and aromatase inhibitors in endometriosis, Current Opinion in Investigational Drugs, 4, 1209
  32. Ward, 1987, Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy, Drugs, 34, 50, 10.2165/00003495-198734010-00003 · DOI · Paper page
  33. Winkel, 2000, A cost-effective approach to the management of endometriosis, Current Opinion in Obstetrics & Gynecology, 12, 317, 10.1097/00001703-200008000-00009 · DOI · Paper page
  34. Winkel, 2003, Evaluation and management of Women with Endometriosis, Obstetrics and Gynecology, 102, 397
  35. Yovich, 1990, Influence of pentoxifylline in severe male factor infertility, Fertility and Sterility, 53, 715, 10.1016/S0015-0282(16)53470-0 · DOI · Paper page
  36. Lu, 2009, Pentoxifylline versus medical therapies for subfertile women with endometriosis, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD007677.pub2 · DOI · Paper page

Cited by

Metadata

Authors
Lu, D., Song, H., Li, Y., Clarke, J., & Shi, G.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2012-01-18
Volume
1
Pages
CD007677-CD007677
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W1689225476
Cited by
38
References
14
FWCI
5.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.